Mirae Asset Global Investments Co., Ltd. Macrogenics Inc Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Macrogenics Inc stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,870 shares of MGNX stock, worth $6,919. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,870
Previous 57,060
96.72%
Holding current value
$6,919
Previous $839,000
99.17%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding MGNX
# of Institutions
154Shares Held
60.6MCall Options Held
218KPut Options Held
259K-
Bellevue Group Ag Kuesnacht, V89.94MShares$36.8 Million0.71% of portfolio
-
Armistice Capital, LLC New York, NY6MShares$22.2 Million0.33% of portfolio
-
Black Rock Inc. New York, NY5.4MShares$20 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.14MShares$15.3 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.31MShares$12.3 Million0.01% of portfolio
About MACROGENICS INC
- Ticker MGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,458,800
- Market Cap $227M
- Description
- MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...